Clinical Trial

Liver Transplant CGM

Recruiting
View on ClinicalTrials.gov →
Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-09.
Trial Details
NCT Number NCT07216508
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Liver Transplant, Post Transplant Diabetes, Type 2 Diabetes
Enrollment 40 participants
Start Date 2025-10-13
Primary Completion 2026-10-05 (estimated)
Study Completion 2027-10-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-12